Top March 2022 FDA Approvals
March 2022 FDA approvals include treatments for Alzheimer disease, endometrial carcinoma, metastatic melanoma, and a genetic seizure disorder.
March 2022 FDA approvals include treatments for Alzheimer disease, endometrial carcinoma, metastatic melanoma, and a genetic seizure disorder.
New legislation addresses mental health and burnout in health care workers, malpractice damage cap and the name change used to describe the PA-physician relationship.
Prevalence of discrimination was reported to be higher among all racial/ethnic minorities than among White participants; those who identify as Asian or American Indian/Alaska Native were most likely to have experienced hostile behavior.
Emergency medicine DNP Dr Duckett refused to take no for an answer when navigating his career path and founded the IMPAC Outreach program for youth.
DNPs offer their personal experiences on responding to microaggressions in the workplace as well as tips on achieving advancements.
New legislation addresses shortages of health care workers in primary care, and states enact laws supporting independent practice authority for APRNs.
February 2022 FDA drug approvals include treatments for bacterial vaginosis, COVID-19, spasticity, and cold agglutinin.
Studies show that adhering to a plant-based diet reduces the risk of chronic conditions, which in turn reduces the risk of severe COVID-19 by 41%.
Hospitals that employ more inpatient NPs show improved patient outcomes, greater staff nurse satisfaction, and lower surgical mortality and cost of care.
January 2022 FDA drug approvals include treatments for asthma, psoriatic arthritis, insomnia, and atopic dermatitis.